PPT-Anti-Infective Solutions

Leading Development of Novel AntiInfective Products in the Era of Increasing Bacterial Resistance October 2017 1 This presentation contains certain statements that constitute forwardlooking statements within the meaning of the federal securities laws Statements that are not historical facts including statements about our beliefs and expectations are forwardlooking statements These statements are not guarantees of future performance and involve risks uncertainties and assumptions that are difficult to predict The forward looking statements in this presentation include statements about our business including commercialization plans and potential markets for our products and product candidates clinical trials potential indications for our product candidates development timelines regulatory timelines and future events that have not yet occurred Pharmaceutical and medical device development inherently involves significant risks and uncertainties including the risks outlined in Risk Factors in our Annual Report on Form 10K filed with the Securities and Exchange Commission and in Risk Factors in our Quarterly Reports on Form 10Q filed with the Securities and Exchange Commission Our actual results may differ materially from our expectations due to these risks and uncertainties including but not limited to our dependence on the success of our lead product candidate Neutrolin and factors relating to commercialization and regulatory approval thereof unpredictability of the size of the markets for and market acceptance of Neutrolin the cost timing and results of the ongoing and planned Phase 3 trials for Neutrolin in the US our need for and ability to raise sufficient capital our ability to identify and enter into strategic transactions intellectual property protection retaining our stocks listing on the NYSE American research and development activities competition industry environment and other matters Any forwardlooking statements included in this presentation are based on information available to us on the date of this presentation We undertake no obligation to update or revise any forwardlooking statement whether as a result of new information future events or otherwise. At Equilibrium, we’re confident we can provide you with the best IT solutions and services for your specific requirements, because we hire only the best. Whether you’re looking for a cloud expert, staffing advice or 24x7 monitoring for your systems, EQ has got you covered. Check out some employee testimonials below and browse our website to learn even more! RHEUMATIC FEVER. Acute, recurrent inflammatory disease . in children 5-15 yrs old (rarely adults). Characterized by inflammatory changes in the fibrous tissue of different organs mainly the heart and joints.. What is the most effective anti-fog solution?. Silas Whitlock. Background-I wear sports glasses but they fog up and I can’t see enough to play in them.. I am going to test different anti-fog solutions from household items and store-bought solutions for swim googles, ski googles, or diving masks to see which one works best. . AES. Sikhar . Patranabis and Abhishek Chakraborty. Under . the supervision of. Dr. Debdeep Mukhopadhyay. Secured Embedded . Architecture Laboratory (SEAL). Outline. Introduction. Differential Fault Analysis (DFA). p. arasitology. Parasitology. is the science dealing with parasites.. Parasites can be classified into:. Helminthes.. Protozoa.. Arthropods.. Medical terms you should know. Parasite. : is a living organism that lives at the expense of its host.. Ms. RIFFAT YASMIN. Contents. Ear Preparations: . Anti infective. Anti inflammatory . Analgesics. 2. Learning objectives. Discus the . Otic. preparations. Categories the . Otic preparations. RAXIBACUMAB. C. 6320. H. 9794. N. 1702. O. 1998. S. 42. 142.8 . kDa. DESCRIPTION. INDICATION. Raxibacumab. is a human IgG1 monoclonal antibody that binds the protective antigen (PA) component of B. . A DISEASE NOT TO BE MISSED. At Risk Group. s. . Initially symptoms may be vague and non specific such as. Low grade fever/chills. Night sweats. Fatigue . Arthralgia. Weight loss. As the disease progresses damage to the heart valves occurs and cardiac signs may be seen. Antifungals. Examples of antifungals. Brand. Generic. Commonly. used for. Nizoral. Ketoconazole. Dandruff and topical infections. Monistat. Miconazole. Vaginal yeast infection. Diflucan. Fluconazole. Authors: Javier Gutierrez Jimenez, F . Cassassuce. , H.A. Najera Aguilar, J.A. Hernandez-. Shilon. , M.A. Schlie-Guzman, S.I. Escobar-. Megchun. Citation: Javier Gutierrez Jimenez, F . Cassassuce. , H.A. Najera Aguilar, J.A. Hernandez-. Miliary Tuberculosis (MTB) is a potentially lethal disease if not diagnosed and treated early. Miliary tuberculosis infection cant health problem in developing countries. Clinical manifestations are kindly visit us at www.examsdump.com. Prepare your certification exams with real time Certification Questions & Answers verified by experienced professionals! We make your certification journey easier as we provide you learning materials to help you to pass your exams from the first try. Professionally researched by Certified Trainers,our preparation materials contribute to industryshighest-99.6% pass rate among our customers. Medications . used to treat bacterial infections. Ideally, before beginning antibiotic therapy, the suspected areas of infection should be cultured to identify the causative organism and potential antibiotic susceptibilities.. selective toxicity. , . spectrum of activity. , . mode of action. , . side effects. , and . resistance of microorganisms . Antimicrobial Side Effects . Allergy. Ototoxicity, nephrotoxicity, and hepatotoxicity.